candesartan cilexetil and hydrochlorothiazide

Solco Healthcare LLC🇺🇸 United States

FDA Page

Effective Date: May 21, 2021
Approval ID: 543b9806-ccfa-4144-a2a2-d0e35eaceeee
Products: 3 registered
Version: 3

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

Candesartan Cilexetil and Hydrochlorothiazide Tablets, 16 mg/12.5 mg, for oral use/Candesartan Cilexetil and Hydrochlorothiazide Tablets, 32 mg/12.5 mg, for oral use/Candesartan Cilexetil and Hydrochlorothiazide Tablets, 32 mg/25 mg, for oral use

Quick Stats

Total Products3

Labelers2

Label Sections14

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.